Use of Animal Models To Support Revising Meningococcal Breakpoints of β-Lactams

Autor: Ana Antunes, Eva Hong, Aude Terrade, Muhamed-Kheir Taha, Nouria Belkacem, Ala-Eddine Deghmane
Přispěvatelé: Centre National de Référence des Méningocoques et Haemophilus influenzae - National Reference Center Meningococci and Haemophilus influenzae (CNR), Institut Pasteur [Paris], The work was supported by the Institut Pasteur., This work used the dynamic imaging facilities of the Imagopole at the Institut Pasteur, Paris, France., Institut Pasteur [Paris] (IP)
Rok vydání: 2016
Předmět:
0301 basic medicine
Antibiotics
MESH: Penicillin G
Neisseria meningitidis
MESH: Meningococcal Infections
medicine.disease_cause
Mice
β lactams
polycyclic compounds
MESH: Animals
Pharmacology (medical)
chemistry.chemical_classification
MESH: Microbial Sensitivity Tests
Strain (chemistry)
Transferrin
Penicillin G
Liter
MESH: Amoxicillin
3. Good health
Infectious Diseases
MESH: Complement Factor H
Complement Factor H
Female
MESH: Transferrin
medicine.drug
MESH: Mice
Transgenic

medicine.drug_class
030106 microbiology
Mice
Transgenic

Microbial Sensitivity Tests
Biology
MESH: Neisseria meningitidis
Microbiology
03 medical and health sciences
medicine
Animals
Humans
MESH: Mice
Pharmacology
MESH: Humans
Interleukin-6
Amoxicillin
MESH: Interleukin-6
[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology
Meningococcal Infections
Penicillin
chemistry
Susceptibility
MESH: Female
Zdroj: Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2016, 60 (7), pp.4023-4027. ⟨10.1128/AAC.00378-16⟩
Antimicrobial Agents and Chemotherapy, 2016, 60 (7), pp.4023-4027. ⟨10.1128/AAC.00378-16⟩
ISSN: 1098-6596
0066-4804
DOI: 10.1128/aac.00378-16
Popis: Antibiotic susceptibility testing (AST) in Neisseria meningitidis is an important part of the management of invasive meningococcal disease. It defines MICs of antibiotics that are used in treatment and/or prophylaxis and that mainly belong to the beta-lactams. The interpretation of the AST results requires breakpoints to classify the isolates into susceptible, intermediate, or resistant. The resistance to penicillin G is defined by a MIC of >0.25 mg/liter, and that of amoxicillin is defined by a MIC of >1 mg/liter. We provide data that may support revision of resistance breakpoints for beta-lactams in meningococci. We used experimental intraperitoneal infection in 8-week-old transgenic female mice expressing human transferrin and human factor H. Dynamic bioluminescence imaging was performed to follow the infection by bioluminescent meningococcus strains with different MICs. Three hours later, infected mice were treated intramuscularly using several doses of amoxicillin or penicillin G. Signal decreased during infection with a meningococcus strain showing a penicillin G MIC of 0.064 mg/liter at all doses. Signals decreased for the strain with a penicillin G MIC of 0.5 mg/liter only after treatment with the highest doses, corresponding to 250,000 units/kg of penicillin G or 200 mg/kg of amoxicillin, although this decrease was at a lower rate than that of the strain with a MIC of 0.064 mg/liter. The decrease in bioluminescent signals was associated with a decrease in the levels of the proinflammatory cytokine interleukin-6 (IL-6). Our data suggest that a high dose of amoxicillin or penicillin G can reduce growth during infection by isolates showing penicillin G MICs of >0.25 mg/liter and ≤1 mg/liter.
Databáze: OpenAIRE